JP2002500189A5 - - Google Patents

Download PDF

Info

Publication number
JP2002500189A5
JP2002500189A5 JP2000527254A JP2000527254A JP2002500189A5 JP 2002500189 A5 JP2002500189 A5 JP 2002500189A5 JP 2000527254 A JP2000527254 A JP 2000527254A JP 2000527254 A JP2000527254 A JP 2000527254A JP 2002500189 A5 JP2002500189 A5 JP 2002500189A5
Authority
JP
Japan
Prior art keywords
taurolidine
resistant
infections
patient
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000527254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002500189A (ja
Filing date
Publication date
Priority claimed from US09/004,063 external-priority patent/US5972933A/en
Application filed filed Critical
Publication of JP2002500189A publication Critical patent/JP2002500189A/ja
Publication of JP2002500189A5 publication Critical patent/JP2002500189A5/ja
Pending legal-status Critical Current

Links

JP2000527254A 1998-01-08 1999-01-06 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用 Pending JP2002500189A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/004,063 1998-01-08
US09/004,063 US5972933A (en) 1998-01-08 1998-01-08 Method of treating microbial infections
PCT/GB1999/000028 WO1999034805A1 (en) 1998-01-08 1999-01-06 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010084729A Division JP5469511B2 (ja) 1998-01-08 2010-04-01 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用

Publications (2)

Publication Number Publication Date
JP2002500189A JP2002500189A (ja) 2002-01-08
JP2002500189A5 true JP2002500189A5 (enExample) 2009-08-20

Family

ID=21708954

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000527254A Pending JP2002500189A (ja) 1998-01-08 1999-01-06 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用
JP2010084729A Expired - Fee Related JP5469511B2 (ja) 1998-01-08 2010-04-01 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010084729A Expired - Fee Related JP5469511B2 (ja) 1998-01-08 2010-04-01 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用

Country Status (8)

Country Link
US (1) US5972933A (enExample)
EP (1) EP1044006B1 (enExample)
JP (2) JP2002500189A (enExample)
AU (1) AU757294B2 (enExample)
CA (1) CA2317748C (enExample)
DE (1) DE69934294T2 (enExample)
ES (1) ES2274614T3 (enExample)
WO (1) WO1999034805A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
CA2393252A1 (en) 1999-12-06 2001-06-07 Paul Calabresi Use of methylol-containing compounds to treat tumors
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
EP1450814B1 (en) 2001-10-01 2016-11-30 Geistlich Pharma AG Methods of inhibiting metastases
US7240441B2 (en) * 2004-02-12 2007-07-10 Mccoy Ted Excavator thumb for use with excavator equipment
JP5227185B2 (ja) * 2006-01-06 2013-07-03 エド・ガイストリッヒ・ゼーネ・アクチェンゲゼルシャフト・フュール・ヒェミッシェ・インドゥストリー 放射線照射された組成物並びにタウロリジン及び／又はタウルルタムを併用する癌の放射線治療
US20080008734A1 (en) * 2006-07-05 2008-01-10 Perrault James J Reduction of skin irritation caused by biomedical electrodes
WO2011097646A1 (en) * 2010-02-08 2011-08-11 Maxlinear, Inc. Methods and apparatus for intelligent power reduction in communications systems
CN103118669B (zh) * 2010-06-01 2016-01-13 盖斯特里希医药公司 口服药物治疗方法和组合物
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
US9951097B2 (en) 2012-12-04 2018-04-24 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
EP3377067A4 (en) * 2015-10-07 2019-07-31 Cormedix Inc. SKIN-PENETRATING FORMULATION OF TAUROLIDINE
WO2018129061A1 (en) * 2017-01-05 2018-07-12 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
US4002889A (en) * 1975-12-08 1977-01-11 Servo Corporation Of America Self-cleaning label for automatic object identification system
US4337251A (en) * 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8424518D0 (en) * 1984-09-28 1984-11-07 Geistlich Sohne Af Fur Chemisc Chemical compounds
GB8514055D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Chemical substance
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8813033D0 (en) * 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
GB8827986D0 (en) * 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
AU665188B2 (en) * 1991-04-15 1995-12-21 Applied Microbiology, Inc Pharmaceutical compositions against gastric disorders
DE69104608T2 (de) * 1991-07-04 1995-02-16 Weissenfluh Hawe Neos Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
AU710109B2 (en) * 1996-01-16 1999-09-16 Ap Pharma, Inc. Topical delivery of drugs to the lower gastrointestinal tract

Similar Documents

Publication Publication Date Title
JP5469511B2 (ja) 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用
ES2339003T3 (es) Rifalazil para tratar infecciones por clostridium difficile.
JP5782615B2 (ja) オリタバンシンの単回用量を用いる治療の方法
JP2002500189A5 (enExample)
US20190194213A1 (en) New use of triazolo(4,5 d)pyrimidine derivatives for prevention and treatment of bacterial infection
US20040147441A1 (en) Methods and reagents for preventing bacteremias
WO2016116892A1 (en) Antibacterial compositions
EP1931388A2 (en) Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
US4749568A (en) Rubradirin treatment of methicillin-resistant staph
EA016803B1 (ru) Лечение инфекционных заболеваний
CN103608013A (zh) 包含抗菌剂和他唑巴坦的组合物
US6858589B2 (en) Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
US10905691B2 (en) Use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection
JPH07503949A (ja) クラブラン酸塩およびエリスロマイシン誘導体よりなる医薬製剤
US20040176349A1 (en) Antibacterial composition
US20210369675A1 (en) Antimicrobial drug methods of use & therapeutic compositions
EA017028B1 (ru) Антибактериальная композиция
US20110319398A1 (en) Inhibition of yops translocation
BR122024018415A2 (pt) Usos de derivados de triazolo(4,5-d) pirimidina, e método para neutralização de bactérias ou prevenção do crescimento bacteriano na formação de biofilme
BR112019003661B1 (pt) Usos de derivados de triazolo(4,5-d) pirimidina, e método para neutralização de bactérias ou prevenção do crescimento bacteriano na formação de biofilme
MX2008004061A (es) Metodos para el tratamiento y la prevencion de la otitis media usando tensioactivos no ionicos para facilitar la entrega trans-membrana de farmacos al oido medio